We considered that the VPS33B heterozygous pathogenic variant may have been a contributing factor to disease development in this patient, given a positive family history, the implications of heterozygous variants in PFIC genes, and the clinical presentation of cholestasis. This evidence concerns the gene ATP8B1 and cholestasis.